The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPets at home Regulatory News (PETS)

Share Price Information for Pets at home (PETS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 283.40
Bid: 237.00
Ask: 290.00
Change: 0.00 (0.00%)
Spread: 53.00 (22.363%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 283.40
PETS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal

1 Dec 2020 07:00

RNS Number : 0205H
Pets At Home Group Plc
01 December 2020
 

FOR IMMEDIATE RELEASE, 01 December 2020

Pets at Home Group Plc: Disposal of Specialist Group

Strategic alignment of customer-centric pet care platform

Pets at Home Group Plc, the UK's leading pet care business, is pleased to announce the disposal of its five Specialist referral practices (the "Specialist Group") to Linnaeus Group for cash consideration of up to £100m.

 

Pets at Home's strategy as the UK's leading pet care business is unchanged, with this disposal being part of the continuing focus of Group resources on customer-facing activities across our omnichannel retailing and First Opinion veterinary operations.

 

The Specialist Group comprises the assets and operations of:

 

- Dick White Referrals in Cambridgeshire

- Anderson Moores in Hampshire

- Northwest Veterinary Specialists in Cheshire

- Eye Vet in Cheshire

- Veterinary Specialists Scotland in Livingston, Scotland

Linnaeus Group, a subsidiary of Mars Veterinary Health, is a veterinary group operating over 150 veterinary clinics across the UK, including highly-respected primary care and referral practices.

 

The disposal of the Specialist Group is for consideration of up to £100m, comprising £80m in cash on completion and deferred cash consideration of £20m, payable upon certain financial milestones being met in the future. The cash proceeds will be retained by the Group for general corporate purposes. The disposal is expected to complete in the first quarter of 2021 and is subject to a limited number of customary conditions and approvals.

 

Peter Pritchard, Group Chief Executive Officer, commented:

"I am very pleased to have agreed the disposal of the Specialist Group to Linnaeus.

 

"Pets at Home is the UK's leading pet care business, across our retail and veterinary operations. This disposal does not deviate from our core focus of providing customers with affordable, convenient, engaging and flexible pet care solutions through our growing online platform and estate of 440 First Opinion veterinary practices and 451 stores. We wish Bart and his team well over the coming years.

 

"The disposal represents a great outcome for all of our stakeholders. Linnaeus is a well-regarded operator of veterinary practices with a strong and established track record of practice management. We hold them in high regard, and they will be a great home for our highly-skilled colleagues in the Specialist Group, underpinned by an ongoing commitment to specialist multi-disciplinary veterinary care, supported by Mars. For our First Opinion Joint Venture Partners and Retail colleagues, the disposal allows realignment of financial and operational resource to support them in doing even more for our customers and their pets. For our shareholders, the disposal proceeds provide the Group with additional resource to accelerate growth across our customer-focused pet care platform."

 

Bart Johnson, CEO of Linnaeus, commented: "We are delighted to welcome our new colleagues and these fantastic and highly-respected referral practices into the Linnaeus family and to grow our offering further, taking another step towards making an even better world for pets".

- End of announcement -

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulations (Regulation (EU) No.596/2014). For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is being made on behalf of the Company by Roger Tejwani, Director of Investor Relations & External Communication.

 

Investor Relations Enquiries

Pets at Home Group Plc:

Roger Tejwani, Director of Investor Relations & External Communication+44 (0)1279 927022

Chris Ridgway, Head of Investor Relations+44 (0)7788 783925

Media Enquiries

Pets at Home Group Plc:

Gillian Hammond, Head of Media & Corporate Affairs+44 (0)7442 500138

Maitland/AMO:

Clinton Manning+44 (0)7711 972662

Frederica Bendit+44 (0)7557 833442

About Pets at Home

Pets at Home Group Plc is the UK's leading pet care business; our commitment is to make sure pets and their owners get the very best advice, products and care. Pet products are available online or from our 451 stores, many of which also have vet practices and grooming salons. Pets at Home also operates a UK leading small animal veterinary business, with 440 First Opinion practices located both in our stores and in standalone locations, as well as five Specialist Referral centres. For more information visit: http://investors.petsathome.com/

 

Disclaimer

This trading statement does not constitute an invitation to underwrite, subscribe for, or otherwise acquire or dispose of any Pets at Home Group Plc shares or other securities nor should it form the basis of or be relied on in connection with any contract or commitment whatsoever. It does not constitute a recommendation regarding any securities. Past performance, including the price at which the Company's securities have been bought or sold in the past, is no guide to future performance and persons needing advice should consult an independent financial adviser. Certain statements in this trading statement constitute forward-looking statements. Any statement in this document that is not a statement of historical fact including, without limitation, those regarding the Company's future plans and expectations, operations, financial performance, financial condition and business is a forward-looking statement. Such forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially. These risks and uncertainties include, among other factors, changing economic, financial, business or other market conditions. These and other factors could adversely affect the outcome and financial effects of the plans and events described in this statement. As a result you are cautioned not to place reliance on such forward-looking statements. Nothing in this statement should be construed as a profit forecast.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISFFFVFLVLIVII
Date   Source Headline
2nd Apr 20248:29 amRNSTotal Voting Rights
26th Mar 20247:00 amRNSFY24 pre-close statement
14th Mar 202410:36 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 202410:31 amRNSResponse to CMA announcement
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20249:43 amRNSTotal Voting Rights
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20244:51 pmRNSHolding(s) in Company
26th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSTransaction in Own Shares
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:00 amRNSTotal Voting Rights
1st Feb 20247:00 amRNSTransaction in Own Shares
31st Jan 20247:00 amRNSTransaction in Own Shares
30th Jan 20247:00 amRNSQ3 FY24 Trading Statement
30th Jan 20247:00 amRNSTransaction in Own Shares
29th Jan 20247:00 amRNSTransaction in Own Shares
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
19th Jan 20247:00 amRNSTransaction in Own Shares
18th Jan 20247:00 amRNSTransaction in Own Shares
17th Jan 20247:00 amRNSTransaction in Own Shares
16th Jan 20247:00 amRNSNotification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.